Compare Elder Pharma with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA UNICHEM LAB ELDER PHARMA/
UNICHEM LAB
 
P/E (TTM) x -0.2 61.9 - View Chart
P/BV x 0.1 0.7 15.2% View Chart
Dividend Yield % 0.0 2.1 -  

Financials

 ELDER PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
UNICHEM LAB
Mar-19
ELDER PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs380292 130.1%   
Low Rs188182 103.3%   
Sales per share (Unadj.) Rs491.2167.7 293.0%  
Earnings per share (Unadj.) Rs-3.2-3.6 87.6%  
Cash flow per share (Unadj.) Rs14.45.9 242.5%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %01.7 0.0%  
Book value per share (Unadj.) Rs376.5372.3 101.1%  
Shares outstanding (eoy) m20.5470.38 29.2%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.61.4 40.9%   
Avg P/E ratio x-89.3-65.3 136.7%  
P/CF ratio (eoy) x19.739.9 49.4%  
Price / Book Value ratio x0.80.6 118.5%  
Dividend payout %0-110.2 0.0%   
Avg Mkt Cap Rs m5,83316,680 35.0%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m2,1792,393 91.0%   
Avg. sales/employee Rs ThNM4,535.2-  
Avg. wages/employee Rs ThNM919.8-  
Avg. net profit/employee Rs ThNM-98.2-  
INCOME DATA
Net Sales Rs m10,08911,801 85.5%  
Other income Rs m257984 26.1%   
Total revenues Rs m10,34612,785 80.9%   
Gross profit Rs m-792-835 94.8%  
Depreciation Rs m361674 53.6%   
Interest Rs m2,75675 3,665.3%   
Profit before tax Rs m-3,653-600 609.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125-343 -36.4%   
Profit after tax Rs m-65-256 25.6%  
Gross profit margin %-7.8-7.1 110.9%  
Effective tax rate %-3.457.3 -6.0%   
Net profit margin %-0.6-2.2 29.9%  
BALANCE SHEET DATA
Current assets Rs m9,24020,384 45.3%   
Current liabilities Rs m9,9985,029 198.8%   
Net working cap to sales %-7.5130.1 -5.8%  
Current ratio x0.94.1 22.8%  
Inventory Days Days46105 44.2%  
Debtors Days Days60135 44.4%  
Net fixed assets Rs m10,1249,023 112.2%   
Share capital Rs m206141 146.1%   
"Free" reserves Rs m5,58226,058 21.4%   
Net worth Rs m7,73426,199 29.5%   
Long term debt Rs m4,8890-   
Total assets Rs m22,88231,496 72.7%  
Interest coverage x-0.3-7.0 4.7%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.40.4 117.7%   
Return on assets %11.8-0.6 -2,054.0%  
Return on equity %-0.8-1.0 86.6%  
Return on capital %22.3-2.0 -1,115.9%  
Exports to sales %3.069.4 4.4%   
Imports to sales %0.40-   
Exports (fob) Rs m3078,188 3.7%   
Imports (cif) Rs m43NA-   
Fx inflow Rs m3078,188 3.7%   
Fx outflow Rs m125596 21.0%   
Net fx Rs m1817,592 2.4%   
CASH FLOW
From Operations Rs m11,754-3,278 -358.6%  
From Investments Rs m-561-2,860 19.6%  
From Financial Activity Rs m-6,762-24 27,941.3%  
Net Cashflow Rs m4,432-4,690 -94.5%  

Share Holding

Indian Promoters % 39.6 50.1 79.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 15.1 49.7%  
FIIs % 16.8 3.0 560.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 31.7 113.9%  
Shareholders   16,479 20,176 81.7%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  TTK HEALTHCARE  PROCTER & GAMBLE HEALTH  

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - SANOFI INDIA COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS